Introduction 48
Dental caries is a polymicrobial biofilm-induced disease affecting 3.5 billion people globally 49 (Kassebaum et al., 2017) . The worldwide annual total costs due to dental diseases are 50 estimated around $545 billions in 2015 (Righolt et al., 2018) . Candida albicans fungus is the 51 etiologic agent of oral thrush and denture stomatitis, the two mucosal oral biofilm infections 52 in immunocompromised patients and in aged peoples, respectively. C. albicans and 53
Streptococcus . Some of the streptococci (e.g. S. mutans) are the causative 57 agents of dental caries and gum disease. Recent studies have shown that a complex 58 interaction and aggregation occurs between streptococci and C. albicans, and the molecular 59 mechanisms are poorly understood (Dutton et al., 2014; Hwang et al., 2017) . 60 61
C. albicans is a commensal and an opportunistic human fungal pathogen found in cutaneous, 62 oral, intestine, genital regions, and can initiate various forms of Candidiasis. While C. 63
albicans is the primary causative agent of oral thrush or oropharyngeal candidiasis in the 64 immune compromised populations (Odds, 1987) , various groups of oral bacteria are shown to 65 interact with C. albicans and influence the disease severity (Dongari-Bagtzoglou et al., 66
2009; Harriott and Noverr, 2011 (Harriott and Noverr, 2009 ) and 70
Acinetobacter baumannii (Uppuluri et al., 2018) use C. albicans hyphae as a substratum for 71 attachment, and forms robust biofilms. 72 C. albicans exists in yeast, pseudohyphae and hyphae. The transition from yeast or 73 pseudohyphae to hyphae is required for its tissue invasion and biofilm formation. Mutants 74 that are defective in hyphal growth are avirulent and unable to form biofilms (Lo et al., 75 1997; Nobile and Mitchell, 2006) . Hence, C. albicans hyphae play a pivotal role in biofilms 76 growth and virulence. Some of the oral bacteria, including S. gordonii are shown to promote 77 the hyphal growths of C. albicans and bind preferably to these hyphal surfaces (Bamford et 78 al., 2009 ). This hyphal binding increased the biofilm mass, and chemical inhibition of 79 candida hyphae reduced the biofilm mass (Bamford et al., 2009 Human saliva collection and processing were done as described previously (Jack et al., 149 2015) . Briefly, unstimulated whole human saliva was collected from at least 5-6 healthy 150 volunteers with Institutional Review Board (IRB) protocol approval (#9130.1) from 151
Kansas State University. All the subjects gave written informed consent approved by the 152 IRB committee. Saliva was pooled and mixed with 2.5 mM dithiothreitol and kept in ice 153
for 10 min before clarification by centrifugation (10,000 × g for 10 min with approximately 2 × 10 6 (CFU/ml) of S. gordonii or/ and 2 × 10 4 (CFU/ml) of C. albicans 167 in the TYES medium with or without GAs. The effect of GAs against biofilm formation was 168 studied using CV staining (Merritt et al., 2005) . Briefly, biofilm was stained with CV, 169
washed twice with PBS to remove excess dye and solubilized by 95% ethanol. The 170 absorbance of the solutions was read at OD595 by a Victor 3v multimode reader (Perkin 171
Elmer, USA). Experiments were repeated at least three times each with triplicates, and 172
representative results are shown. 173 174
Measurement of biofilm extracellular DNA (eDNA) 175 176 eDNA were measured as per the standard protocol described elsewhere (Jack et al., 2015) . 177
Briefly, biofilms were scraped from saliva coated wells or sHA disc into 0.5 mL TE buffer 178 (10 mM Tris/HCl, pH 7.5 and 1mM EDTA), cell free DNA was collected by centrifugation at 179 10,000 × g for 5 min. The DNA concentration was then analyzed from the supernatant using 180 a NanoDrop 2000 spectrophotometer (Thermo Scientific, USA Corporation, Madison, WI, USA) and primers was carried out in a 20 μL reaction volume 201
(1 μL cDNA, 10 μL Master Mix, 0.5 μM of each primer). Primer details are given in Tables  202 1 and 2. The internal control used was 16S rRNA for S. gordonii and TDH3 for C. albicans. 203
The cycling conditions consisted of initial denaturation at 94°C for 3 min followed by 204 denaturation at 94°C for 30 seconds, annealing at 50°C or 58°C for 30 seconds, and 205 extension at 72°C for 45 seconds, then final extension at 72°C for 7 min. Twenty 206 microliters of each PCR product was electrophoresed on agarose gel (1.2% w/v) containing 207 ethidium bromide (0.5 μg/ml). Images of the amplified products were acquired with an 208 Alpha Imager; the intensity was quantified using the image J software (NIH, USA). The 209
band intensity was expressed as mRNA expression in fold (specific gene 210 expression/internal control gene expression). The expression of the control cells without 211 treatment was taken as one and it was compared with the treated group. 212 213
Cloning, Expression, and Purification of rGAPDH 214 215
GAPDH gene from S. gordonii was PCR amplified using primers GAPDH-F (5′-216 ATTCCATATGGTAGTTAAAGTTGGTATTAACGGT -3′) and GAPDH-R (5′-217 GCGCTCGAGTTTAGCGATTTTCGCGAAGTATTCAAG -3′) where the underlined 218 sequences in the forward and in reverse primers indicate NdeI and XhoI restriction sites, 219 respectively. Following PCR amplification of chromosomal DNA from S. gordonii strain 220 ATCC 10558, amplicons of 1008 bp were digested with NdeI and XhoI and inserted into the 221 predigested pET28b plasmid (Novagen, Madison, WI). Successful cloning of the gene was 222 confirmed by restriction endonuclease and DNA sequence analyses (data not shown). 223
Recombinant plasmid was transformed into E. coli BL21 (DE3) for overexpression. 224
Expression of GAPDH-6His protein was induced with 1mM isopropyl-β-d-225 thiogalactopyranoside (IPTG) when cultures reached an optical density at 600 nm (OD600) 226 of 0.6, and cells were harvested after 4 h. The cell pellet from 2 L of culture was resuspended 227 in 40 ml of a buffer containing 50mM NaH2PO4 pH 8.0, 300mM NaCl, 20mM imidazole 228 with 1x protease inhibitor cocktail (Roche) and 1mM phenylmethylsulfonyl fluoride (PMSF), 229 and cells were lysed by French press (~19,000 psi). The lysate was centrifuged at 10,000 g 230
for 20 min at 4˚C. Recombinant His-tagged GAPDH was purified using Ni-NTA Agarose 231 (Qiagen, Valencia, USA) in native conditions according to the manufacturer's 232 recommendations. GAPDH was eluted using gradients of increasing imidazole concentration 233 (100-300mM S. gordonii and C. albicans co-exist in the oral cavity as abundant microbes, and the former is 269 known to attach on the hyphal surfaces of the latter forming a mixed species biofilm with 270 enhanced virulence. Preventing the growth of these biofilms by nontoxic small molecules 271 would limit oral diseases and their dissemination systemically. A previous study from this 272 laboratory showed that GAs prevent C. albicans yeast-to-hypha transition and its hyphal 273 growth without affecting the growth of yeast form and viability (Vediyappan et al., 2013) . 274
Based on these results, we predicted that lack of hyphae as substrates or its surface molecules 275 due to GAs effect would preclude the binding of bacteria to them and thus could prevent the 276 growth of mixed biofilms. However, the impact of GAs on S. gordonii' biofilms growth and 277 or its hypha inducing effect on C. albicans during mixed biofilm growth is unknown. First, 278
we wanted to determine the MBIC of GAs. To determine the minimum amount of GAs 279 needed to inhibit maximum biofilm growth of S. gordonii, MBIC assay was performed with 280 increasing concentrations of GAs (0 to 1000 µg/mL). Biofilms were quantified by CV 281 staining and the results showed a concentration-dependent antibiofilm activity of GAs against 282 S. gordonii ( Figure 1A) . A significant inhibition was found from concentration >400 µg/mL. 283 284
To determine if GAs are toxic to S. gordonii, we measured its growth kinetics as planktonic 285 cells in the presence or absence of GAs using Bioscreen-C growth monitor at 37 o C in TYES 286 medium as described in the method section. Since GAs inhibited S. gordonii biofilms growth 287 from concentration 400 g/ml or above, we used three different concentrations of GAs (400,  288 500 & 600 g/ml) to assess its effects. As shown in Figure 1B , the overall growth kinetics of 289
S. gordonii in the presence or absence of GAs is parallel except the wells with GAs showed a 290 reduced growth rate. While S. gorodonii exposed to 400 & 500μg/ml GAs show similar 291 growth pattern, GAs at 600μg/ml affect S. gordonii growth even further. Taken together, GAs 292
were inhibiting the growth of S. gordonii moderately at 400 -600μg/ml under the growth 293 conditions used. Since 500μg /ml GAs inhibited maximum biofilm growth, we employed this 294 concentration (500μg/ml) throughout the study to determine its effect on mono-or dual-295 species biofilms. 296 297
Inhibition of S. gordonii and C. albicans mono-and dual-species biofilms grown in 24-298 well microtiter plates by GAs 299 300
The antibiofilm efficacy of GAs was assessed under in vitro condition by measuring the 301 binding of CV to S. gordonii biofilms cells in 24-well plates. The antibiofilm activity of GAs 302 was effective at 500μg/ml against S. gordonii and C. albicans mono-and dual-species 303 biofilms (Figure 2A ). GAs treatment significantly reduced the amount of S. gordonii biofilms 304 (Figure 2A) . Similarly, the mixed biofilms were also reduced with GAs treatment and are 305 significant as analyzed by one-way ANOVA (p = 0.001). 306 307
GAs treatment effectively reduces eDNA in mono-and dual-species biofilms 308 309
Extracellular DNA (eDNA) is known to be released during biofilm growth and is an integral 310 part of polymeric material (Xu and Kreth, 2013) . To examine the effects of GAs on biofilm 311 eDNA, mono-and dual-species biofilms were grown in TYES medium. High level of eDNA 312
were found in both mono-and dual-species biofilms. Interestingly, significant reduction in 313 eDNA concentrations were observed in these biofilms treated with GAs (p = 0.001, Figure  314 2B). 315 316
Inhibition of S. gordonii and C. albicans mono-and dual-species biofilms on sHA discs 317 318
SEM analysis was carried out to examine the structures of mono-and dual-species biofilms 319
formed on sHA discs that were treated with and without GAs. Biofilms formed on sHA discs 320 were fixed, stained with alcian blue and processed as described (Erlandsen et al., 2004) . SEM 321 micrographs of S. gordonii revealed the formation of biofilms with thick aggregates of cells 322 on the surface of sHA containing patches of exopolysaccharide (EPS) ( Figure 3A ). 323
Interestingly, very little biofilms of S. gordonii was found on the GAs treated sHA disc, and 324 large empty areas were seen mostly ( Figure 3G ). These SEM results agree with in vitro 325 biofilm growth assay ( Figure 2A ). As expected, C. albicans control biofilms (B) contain 326 multilayers of hyphae and in the GAs exposed biofilms, very little yeast and pseudohyphal 327 cells were present on the sHA discs (H-I). Although GAs does not inhibit the yeast fungal 328 growth rate at the concentration used (Vediyappan et al., 2013) , the yeast-pseudohyphal cells 329 produced due to GAs treatment poorly or could not be attached to the sHA discs or to the 330 other surfaces (unpublished results). S. gordonii and C. albicans dual biofilms (C) contained 331 both bacterial and fungal hyphal cells densely, and their abundance decreased by GAs 332 treatment ( Figure 3I ). 333 334
Treatment with GAs significantly reduced extracellular nanofibrillar based biofilm 335 formation 336 337
In order to get better insight, we then viewed these biofilms closely at higher magnification 338 (50, 000x). In S. gordonii biofilms without GAs exposure, we found short fibrils between S. 339
gordonii cells [and some of these fibrils were attached to sHA] ( Figure 3D, arrows) . As 340 expected, C. albicans biofilms without GAs treatment produced mostly hyphae. Interestingly, 341
C. albicans biofilms co-cultured with S. gordonii (dual biofilms) without GAs showed 342 several closely attached bacterial-fungal cells with abundant extracellular materials. 343 Strikingly, we found several thin fibrils from hypha that is in close contact with the sHA disc 344
( Figure 3F, boxed when compared with their respective controls ( Figure 5A ). Interestingly, the expression of 363 ldh was enhanced 9-fold in GAs treated S. gordonii mono-biofilms but not in dual biofilms 364 ( Figure 5A ). In mono-biofilms of C. albicans, the expression of NRG1 was increased 2 fold 365
in GAs treated samples compared to the untreated control ( Figure 5B ). No change was 366 observed for NRG1 and CSH1 in GAs treated dual biofilms. The expression of PRA1 was 367 increased 2 fold in GAs exposed C. abicans mono-biofilms. Whereas, in dual-species 368 biofilms the expression of PRA1 was inverse in GAs treated biofilms. In contrast, ZRT1, the 369 regulator of PRA1, was overexpressed about 5 fold in dual-species biofilms in the presence of 370
GAs but not in the GAs exposed C. albicans mono-biofilms. 371 372
GAs inhibit the GAPDH activity 373 374
To assess the potential inhibitory activity of GAs against the GAPDH from S. gordonii, we 375 cloned the gene, overexpressed and purified the rGAPDH protein using the E. coli expression 376 system ( Figure 6A ). The purified rGAPDH migrated at an apparent molecular weight of ~40 377 kDa and reacted to polyclonal anti-GAPDH antibody ( Figure 6B ). We next tested the effect 378 of GAs (100 and 200µM) against the purified rGAPDH protein (0.1 µM). The assay depends 379 on the conversion of glyceraldehyde-3-phosphate to 1,3-diphosphoglycerate by GAPDH 380 enzyme in the presence of NAD. Interestingly, GAs appears to bind to GAPDH protein and 381 block its enzyme activity in a dose-dependent manner. At 200µM concentration, GAs block 382 the activity of GAPDH completely when compared to the reaction without GAs where it 383
shows strong enzyme activity ( Figure 6C ). leads to stable colonization in the oral cavity and also attaches to C. albicans hyphae via 391 protein-protein interactions . In addition, S. gordonii colonization on the 392 tooth surface allows other microbes to adhere and develop mixed biofilms such as dental 393 caries, which is the most prevalent human oral diseases, especially among the children. We 394 have investigated the S. gordonii mono-and S. gordonii -C. albicans dual-species biofilms 395
and their inhibition by gymnemic acids (GAs) in vitro. GAs, a medicinal plant-derived small 396 molecule, was shown to prevent C. albicans yeast-to-hypha transition and hyphal growth 397 without affecting its viability or yeast growth rate (Vediyappan et al., 2013) . However, GAs' 398 effect on bacterial and or bacterial-fungal mixed biofilms are unknown. GAs are a family of 399 triterpenoid saponin compounds which are the major active principles of Gymnema sylvestre 400 plant leaves. The extract of this plant is widely used for its various medicinal properties 401
including lowering blood glucose activity in diabetic patients and reducing obesity 402 (Porchezhian and Dobriyal, 2003; Leach, 2007; Zuniga et al., 2017) . 403 404
Antibiofilm efficacy of GAs was investigated in terms of CV staining and eDNA reduction, 405
where the results found to be significant compared to untreated controls. This is the first 406 report to provide evidence that the GAs shows antibiofilm efficacy against both mono-and could substantively diminish the development of biofilm formation. As such, we found that 414
GAs was able to reduce a significant amount of eDNA being released by both mono-and 415 dual-species biofilms (Figures 1 & 2 synthesis of these fibrils were abolished in the GAs treated S. gordonii biofilms. These fibrils 427 could be related to EPS and we believe GAs might be affecting their synthesis and or their 428 incorporation into the biofilms. One of the unexpected findings of S. gordonii-C. albicans 429 mixed biofilms was the formation of short fibrils from the C. albicans hyphae ( Figure 4A &  430  B ). These fibrils show attachment to neighboring hypha and to the sHA substratum. This 431
shows that there is an enhanced mutual synergism between these two microbes. However, in 432
GAs treated mixed biofilms, these fibrils were absent ( Figure 3L ) and found significant 433 inhibition of biofilms. Djaczenko and Cassone (1971) have reported the presence of fimbriae 434 in C. albicans yeast cells and known to contain mannosylated glycoprotein (Yu et al., 1994) . 435 We believe the fibrils that we observe in hyphae could be different from the fimbriae 436 described above. For example, the fimbriae reported by Djaczenko and Cassone (Djackenko 437 and Cassone, 1971) were found on the surface of 'yeast cells' grown on agar plates for 438 several days. These fimbriae are short and continuous throughout the cell surface of mother 439 yeast cells but very little on the daughter cells. 440
In contrast, our results show the fibrils are discontinuous and found only from hyphae of S. 441
gordonii-C. albicans co-cultured biofilms where they have close contacts with abiotic or 442 biotic surfaces (Figure 4 ). These fibrils were not observed in biofilms grown in the presence 443 of GA, suggesting that GA can prevent adhesive fibrils, in part, by inhibiting its synthesis and 444 or hyphae associated mannoproteins. 445 446
To understand the mechanisms of biofilms inhibition by GAs, we next determined the 447 expression of a few selected genes that have predicted roles in the growths of S. gordonii and 448
C. albicans biofilms. EPSs are the core parts for the assembly and maintenance of biofilm 449 architectural integrity in the oral cavity. The oral streptococci produce glucosyltransferase 450 enzymes, Gtfs, that catalyze extracellular glucose into glucan polymer, which helps the 451 streptococci adhere to the tooth surface and to the surfaces of other oral microbes. S. 452
gordonii, the primary colonizer of the oral cavity, produces gtfG (Vickerman et al., 1997) . 453
The RT-PCR analysis of S. gordonii biofilm cells shows basal level expression of gtfG. 454
However, GAs treatment reduced its expression, signifies the inhibitory potential of biofilm 455 glucan by GAs. This result agrees with SEM data where the S. gordonii biofilms treated with 456
GAs show absence of adhesive fibrils when compared to the control biofilm where the fibrils 457
can be seen between the biofilms cells and on the sHA ( Figure 5) . Liver X-receptor (LXR) that regulates lipid metabolism in the liver (Renga et al., 2015) . It 462 has been reported that administration of GAs containing fraction, GS4, decreased the 463 glycosylated hemoglobin (HbA1c) and glycosylated plasma protein in diabetic patients 464 (Baskaran et al., 1990 ) and a similar mechanism may occur in microbial biofilms. Bacterial 465
Gtfs play a critical role in enhancing the accumulation of C. albicans cells during mixed 466 biofilms growths (Ellepola et al., 2017) . Similarly, mannosyltransferase genes (MNT1/2) of 467 C. albicans are involved in O-mannosylation of proteins in the hyphal surfaces that allow S. 468
gordonii-C. albicans interaction and promote mixed biofilms (Dutton et al., 2014) . In a 469 separate study, we have observed that the treatment of C. albicans biofilms with GAs 470 affected many of its mannosylated proteins (McMillan et. al. manuscript in preparation). 471
Thus, GAs appears to modulate glycan transferases from both S. gordonii and C. albicans. 472
GAs may also affect the polysaccharide synthesis pathway in S. gordonii biofilms, through a 473 reduced gtfG expression and or its enzyme activity. Further, Gtfs use metal co-factor Mn 2+ 474 for enzyme catalytic activity (Zhu et al., 2015) and the downregulation of scaA, the gene that 475 encodes Mn 2+ binding lipoprotein, in GAs treated S. gordonii mono-as well as dual-species 476 biofilms ( Figure 5 ) may also contribute to the reduction of adhesive fibrils/polysaccharides. 477
For growth and survival in the human host, S. gordonii will have to acquire Mn 2+ with the 478 help of ScaA, a prominent surface antigen. It has been shown that inactivation of scaA gene 479 resulted in both impaired growth of cells and >70% inhibition of Mn 2+ uptake (Kolenbrander 480 et al., 1998) . 481 482
Oral bacteria including, S. gordonii, can sense the redox status of the biofilm niche and 483 respond accordingly. Among the genes examined for differential expression in biofilms, we 484 found lactate dehydrogenase (ldh) is one of the highly upregulated genes in GAs treated 485 biofilms of S. gordonii ( Figure 5 ). The ldh enzyme interconverts pyruvate into lactate and 486 back, as it converts NADH to NAD and back. In GAs treated S. gordonii, ldh may be 487 converting lactate into pyruvate as the gapdh mRNA is downregulated in GAs treated mono-488 or mixed biofilms of S. gordonii but not in C. albicans. GAPDH uses NAD during glycolytic 489 activity and the reduced amount of GAPDH may lead to the accumulation of NAD, which in 490 turn activates the overexpression of ldh through a redox-sensing system (Bitoun and Wen, 491 2016). To determine if GAs has any effect on GAPDH enzyme activity, we cloned the gapdh 492 gene from S. gordonii, overexpressed in E. coli and tested the purified rGAPDH with or 493 without GAs. We found the inhibition of rGAPDH enzyme activity in a dose-dependent 494 manner ( Figure 6 ). GA was shown to inhibit rabbit GAPDH enzyme activity (Izutani et al., 495 2005 (Kuboniwa et al., 2017) . In addition to glycolytic function, GAPDH is 499 also a moonlighting protein and known to carry out multiple functions (Sirover, 2017) . It is 500 worth mentioning that natural products (anacardic acid and curcumin) are shown to bind and 501 inhibit S. pyogenes GAPDH activity, one of the major virulence factors (Gomez et al., 2019) 502 and the GAPDH serves as a drug target in other pathogens (Freitas et al., 2009 ) as well. GAs 503 appear to impact on S. gordonii GAPDH both at the transcriptional and translational level and 504 could account, at least partially, for the observed inhibition of S. gordonii growth or biofilm. 505
Comparison of amino acid sequences of both S. gordonii and C. albicans GAPDH revealed 506 about 50% similarity and thus GAs impact on them could be different. In fact, the expression 507 of GAPDH gene in C. albicans (TDH3) biofilms grown in the presence or absence of GAs is 508 not affected ( Figure 5B , TDH3 RT-PCR bands). However, GAs impact on C. albicans 509 GAPDH (Tdh3) enzyme activity and its role in biofilms can't be ruled out and remains to be 510 determined. Further, the global gene expression and biochemical analyses could reveal the 511 complete mechanism(s) of GAs-mediated inhibition of S. gordonii mono-and mixed 512 biofilms. 513 514
Among the genes examined in C. albicans mono-or dual-species biofilms, NRG1, PRA1 and 515
ZRT1 are the most differentially expressed genes. It is well known from the literature that 516
Nrg1 of C. albicans, is a DNA binding protein that represses its filamentous growth (Braun et 517 al., 2001) . GAs treatment shows a significant increase of NRG1 mRNA expression in C. 518
albicans biofilms compared to control biofilms ( Figure 5B ), which may correspond to the 519 observed yeast or pseudohyphal growth forms of C. albicans mono-species biofilm ( Figure  520 3). However, no change of NRG1 expression level was observed in dual-species biofilms yet 521 their biofilms growths were inhibited underscoring the unknown regulatory mechanism in the 522
GAs treated dual biofilms. C. albicans sequesters environmental zinc through a secreted 523 protein, the pH-regulated antigen 1 (Pra1) and transports it through the membrane transporter 524 (Zrt1) for its invasive growth in the host (Citiulo et al., 2012) . C. albicans has biphasic 525 mechanisms for its environmental and cellular zinc homeostasis and Pra1 expresses when 526 cells are at pH 7 and above or at zinc limitation (Crawford et al., 2018; Wilson, 2019) . GAs 527 treatment to C. albicans mono-biofilm appears to cause zinc limitation and or change in 528 cellular pH, which could be altered when grown with S. gordonii as mixed-species biofilms 529 ( Figure 5B ). 530 531
Our understanding about mixed species biofilms in caries pathogenesis was not studied well 532 and still in its infancy (Metwalli et al., 2013 results represent means ± standard deviations for three independent experiments. NS-not 876 significant, *p < 0.05, **p < 0.01, ***p < 0.001. 
